Surgery News and Research

RSS

Study suggests potential therapeutic role of aspirin in inhibiting vestibular schwannoma growth

Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated, for the first time, that aspirin intake correlates with halted growth of vestibular schwannomas (also known as acoustic neuromas), a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

24 Jan 2014

Loyola professor receives prestigious Presidential Early Career Award for Scientists and Engineers

Katherine Radek, PhD, of Loyola University Chicago Stritch School of Medicine, has received a prestigious Presidential Early Career Award for Scientists and Engineers.

24 Jan 2014

FDA grants final approval for Hi-Tech Pharmacal's Bromfenac Ophthalmic Solution ANDA

Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, granted final approval for the Company's Abbreviated New Drug Application, for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day), the generic for ISTA Pharmaceuticals' Bromday ophthalmic solution, 0.09%.

23 Jan 2014

Gulf Coast Spine Care now offers new, improved treatment for degenerative disc disease

Degenerative disc disease affects many individuals, and it can cause a significant amount of pain to those affected. Its most common cause is related to aging and deterioration of the bones in the spine, and pain from the condition results when two or more vertebrae move and place pressure on the spine. This is a condition that often is associated with both a herniated disc and spinal stenosis.

23 Jan 2014

New tools to increase precision and safety of radiation treatment in cancer patients

A scientific breakthrough may give the field of radiation oncology new tools to increase the precision and safety of radiation treatment in cancer patients by helping doctors "see" the powerful beams of a linear accelerator as they enter or exit the body.

23 Jan 2014

Number of cancer stem cells in tumor might inaccurately estimate tumor's recurrence or progression

New research from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that it may be the quality of cancer stem cells rather than their quantity that leads to better survival in certain patients with oral cancer.

23 Jan 2014

Nearly half of hospitalized American adults age 65 require decision-making assistance

Nearly half of hospitalized American adults age 65 and older require decision-making assistance from family members or other surrogates because the patient is too impaired to make decisions independently, according to a new study from the Regenstrief Institute and the Indiana University Center for Aging Research.

23 Jan 2014

ECMO: A last-resort therapy for extremely severe cases of influenza

Physicians at the University of Alabama at Birmingham are employing a technology known as ECMO as a last-resort therapy for extremely severe cases of influenza. ECMO, short for extracorporeal membrane oxygenation, is a sort of portable heart/lung bypass machine.

23 Jan 2014

New scientific article shows that Patrys' PAT-SC1 safe, well-tolerated in gastric cancer patients

Patrys Limited, a clinical stage biotechnology company is pleased to announce the publication of a new scientific article regarding its product PAT-SC1 in the Oncology Reports journal. The article is currently available online and will be included in a future print edition of the journal.

22 Jan 2014

UC researchers receive more than $1M grant to study complex traumatic injuries of warfare

Trauma and critical care researchers at the University of Cincinnati (UC) have received more than $1 million from the United States Air Force in a recent set of grant awards to study how air medical evacuation affects patients, medical professionals and medical equipment.

22 Jan 2014

Adverse events for patients treated for heart attack and heart failure have declined, study finds

Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.

22 Jan 2014

Advanced melanoma treatments: an interview with Dr. James Larkin, Consultant Medical Oncologist, The Royal Marsden

Advanced melanoma affects around 2,000 people per year in the UK. Advanced melanoma describes a melanoma that has spread from its site of origin to other areas of the body.

22 Jan 2014

ASA's recommendations to help patients avoid unnecessary tests for chronic pain

Not prescribing opioids first or as a long-term therapy for chronic, non-cancer pain and avoiding MRIs, CTs and X-rays for low-back pain are among the tests and treatments identified by ASA that are commonly ordered but not always necessary.

22 Jan 2014

Clues of "silent thief of sight”: Glaucoma

Glaucoma is sometimes called the "silent thief of sight" because it slowly damages the eyes and can cause irreparable harm before there is any vision loss. But this disease is stealthy in more ways than one.

22 Jan 2014

Longer withdrawal times during colonoscopy correlates with higher rate of polyp detection

Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) researchers found that longer withdrawal times during a colonoscopy correlates with a higher rate of polyp detection. The study was recently published online in in the American Journal of Gastroenterology.

22 Jan 2014

Mesothelioma patients treated with radiation before surgery experience speedier recovery

Results of clinical research that treated mesothelioma with radiation before surgery show the three-year survival rate more than doubled for study participants afflicted with this deadly disease, compared to treating with surgery first.

21 Jan 2014

Agenus' Prophage vaccine Phase 2 study hailed in Neuro-Oncology journal

Agenus Inc., a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, announced that Phase 2 results of Prophage G-200 vaccine in recurrent patients with glioblastoma multiforme were hailed as 'exciting' and a 'very promising therapy' in an editorial published in Neuro-Oncology, the leading journal of the Society of Neuro-Oncology.

21 Jan 2014

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Advaxis, Inc., a leader in developing the next generation of cancer immunotherapies, announced that the first patient has been dosed in a Phase 1/2 "window of opportunity" study being conducted by the Icahn School of Medicine at Mount Sinai. Patients diagnosed with HPV-associated head and neck cancer will receive ADXS-HPV immunotherapy during the "window" of time between initial diagnosis and minimally invasive transoral robotic surgery to remove their tumors.

21 Jan 2014

BioLineRx gets approval to begin CE Mark registration trial of BL-5010P for skin lesion treatment

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to commence a pivotal, CE Mark registration trial for BL-5010P, for the non-surgical removal of benign skin lesions.

21 Jan 2014

Bariatric surgeon educates patients about bariatric surgeries to achieve healthy weight

While many Americans make New Year's resolutions focused on self-improvement, those who are overweight or obese likely prioritize getting down to a healthy weight.

21 Jan 2014

Surgery News and Research

Study suggests potential therapeutic role of aspirin in inhibiting vestibular schwannoma growth

Loyola professor receives prestigious Presidential Early Career Award for Scientists and Engineers

FDA grants final approval for Hi-Tech Pharmacal's Bromfenac Ophthalmic Solution ANDA

Gulf Coast Spine Care now offers new, improved treatment for degenerative disc disease

New tools to increase precision and safety of radiation treatment in cancer patients

Number of cancer stem cells in tumor might inaccurately estimate tumor's recurrence or progression

Nearly half of hospitalized American adults age 65 require decision-making assistance

ECMO: A last-resort therapy for extremely severe cases of influenza

New scientific article shows that Patrys' PAT-SC1 safe, well-tolerated in gastric cancer patients

UC researchers receive more than $1M grant to study complex traumatic injuries of warfare

Adverse events for patients treated for heart attack and heart failure have declined, study finds

Advanced melanoma treatments: an interview with Dr. James Larkin, Consultant Medical Oncologist, The Royal Marsden

ASA's recommendations to help patients avoid unnecessary tests for chronic pain

Clues of "silent thief of sight”: Glaucoma

Longer withdrawal times during colonoscopy correlates with higher rate of polyp detection

Mesothelioma patients treated with radiation before surgery experience speedier recovery

Agenus' Prophage vaccine Phase 2 study hailed in Neuro-Oncology journal

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

BioLineRx gets approval to begin CE Mark registration trial of BL-5010P for skin lesion treatment

Bariatric surgeon educates patients about bariatric surgeries to achieve healthy weight

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News